ArticleIJID regions2025
Clinical and laboratory profiles of dengue infection in the hospitals in North Jakarta, Indonesia.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Detection of Dengue Virus and Serological Evidence of Chikungunya and Zika Virus Exposure in Patients with Acute Febrile Syndrome in Córdoba, Colombia.Tropical medicine and infectious disease · 2026Article
- Early diagnostic value of dengue virus NS1 antigen and nucleic acid testing.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Indonesia is one of the dengue endemic countries. The criteria for diagnosing dengue infection are based on World Health Organization (WHO) guidelines. Chikungunya and Zika virus infections have also been reported sporadically in Indonesia. This study aimed to evaluate the clinical features of patients with dengue in a hospital setting and investigate the potential for other arboviral infections in patients with fever. Methods: This case-control study was conducted at two hospitals in North Jakarta between August 2023 and May 2024. Patients admitted with 3 or more days of fever without any proven cause of bacterial infection or autoimmune disease were recruited. The cases were those who tested positive for Dengue, Chikunguya, Zika, and West Nile viruses by multiplex reverse transcription-quantitative polymerase chain reaction, whereas the controls were those who tested negative. Questionnaires were used to collect the signs and symptoms. Blood tests were conducted using autoanalyzers. Chi-square and Student's Results: Of the 135 respondents, 70 tested positive for dengue and two tested positive for chikungunya using multiplex reverse transcription-quantitative polymerase chain reaction. Having fever with two additional two signs and symptoms, as per the WHO guidelines, is predictive of dengue infection. Leukopenia and thrombocytopenia were significantly more common in dengue cases. An increase in hematocrit was inconclusive. Serum aspartate transaminase levels are also increased in patients with dengue. The dengue virus nonstructural protein-1 antigen test is the preferred point-of-care test for the diagnosis of dengue virus infections. Conclusions: Our investigation confirmed that the WHO guidelines for diagnosing dengue are still applicable. The Chikungunya virus also circulates in Jakarta, and physicians should be aware of this.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.